Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients

Journal of Nephrology

Volumn 18, Issue 1, 2005, Pages 72-79

  Fusaro, Maria ^a   Munaretto, Giorgio ^a   Spinello, Michela ^a   Rebeschini, Mirca ^a   Amici, Gianpaolo ^b   Gallieni, Maurizio ^c   Piccoli, Antonio ^d  

^a Hospital of Chioggia   (Italy)

^b Hospital of Treviso   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anemia; Dialysis; Iron; Reticulocyte hemoglobin concentration; Soluble transferrin receptor

Indexed keywords

BICARBONATE; BIOCHEMICAL MARKER; CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FERROUS GLUCONATE; FOLIC ACID; HEMOGLOBIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CHRONIC PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DOSE RESPONSE; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; MALE; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; RETICULOCYTE; SENSITIVITY ANALYSIS; SOLUBILITY; TRANSFERRIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; OSMOLARITY; RENAL REPLACEMENT THERAPY;

AGED; ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RECEPTORS, TRANSFERRIN; RENAL DIALYSIS; RETICULOCYTES;

EID: 16844385332     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001; 16: 1416-23.
2. National Kidney Foundation - Dialysis Outcomes Quality Initiative: NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 2001; 37 (suppl 1): S182-238.
3. Triolo G, Di Giulio S, Brancaccio D, Canavese C, Carozzi S, Cianciaruso B, Panzetta G, Piccoli A. Linee Guida per il trattamento dell'anemia nell'insufficienza renale. G Ital Nefrol 1999; 16 (suppl 6): S41-53.
4. Tarng D, Huang T, Chen TW, Yang W. Erythropoietin hyporesponsiveness: From iron deficiency to iron overload. Kidney Int 1999; 55 (suppl 69): S107-18.
5. Fishbane S, Kowalski EA, Imbriano LJ, Maesaka JK. The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996; 7: 2654-7.
6. Besarab A, Kaiser JW, Frinak S. A study of parenteral iron regimens in hemodialysis patients. Am J Kidney Dis 1999; 34: 21-8.
7. Besarab A, Amin N, Ahsan M, Vogel SE, Zazuwa G, Frinak S, Zazra JJ, Anandan JV, Gupta A. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 2000; 11: 530-8.
8. Fishbane S, Lynn RI. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients. Am J Kidney Dis 1995; 25: 426-32.
9. Tarng DC, Huang TP. Determinants of circulating soluble transferrin receptor level in chronic hemodialysis patients. Nephrol Dial Transplant 2002; 17: 1063-9.
10. Brugnara C. Reticulocyte hemoglobin content (CHr): Early indicator of iron deficiency and response to therapy. Blood 1994; 83: 3100-1.
11. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-22.
12. Cullen P, Soffker J, Hopfl M, Bremer C, Schlaghecken R, Mehrens T, Assmann G, Schaefer RM. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999; 14: 659-65.
13. Braun J, Hammerschmidt M, Schreiber M, Heidler R, Horl WH. Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients? Nephrol Dial Transplant 1996; 11: 492-7.
14. Ahluwalia N, Skikne BS, Savin V, Chonko A. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis 1997; 30: 532-41.
15. D'Onofrio G, Chirillo R, Zini G, Caenaro G, Tommasi M, Micciulli G. Simultaneous measurement of reticulocyte and red blood cell indexes in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995; 85: 818-82.
16. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89: 1052-5.
17. Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997; 30: 912-22.
18. Kaneko Y, Miyazaki S, Hirasawa Y, Gejyo F, Suzuki M. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients. Kidney Int 2003; 63: 1086-93.
19. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-11.
20. Brugnara C, Colella GM, Cremins J, Langley RC Jr, Schneider TJ, Rutherford CJ, Goldberg MA. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron deficient erythropoiesis. J Lab Clin Med 1994; 123: 660-7.
21. Huebers HA, Beguin Y, Pootrakull P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990; 75: 102-7.
22. Zeki Tonbul H, Kaya H, Selcuk Y, San A, Akcay F, Tekin SB. Serum transferrin receptor level in the diagnosis of iron deficiency due to erythropoietin therapy. Nephron 1998; 80: 241-7.
23. Deira-Lorenzo J, Rodriguez MM, Sànchez Martin S, Tabernero Romo JM. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements. Am J Kidney Dis 2001; 37: 550-6.
24. Cazzola M, Beguin Y. New tools for clinical evaluation of erythropoiesis and iron status in man. Br J Haematol 1992; 80: 278-84.
25. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992; 19: 385-90.
26. Petterson T, Kivivuori SM, Siimes MA. Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases? Br J Haematol 1994; 33: 740-4.
27. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998; 44: 45-51.